Are we scanning testis cancer patients too often?

Cancer

Volumn 117, Issue 18, 2011, Pages 4108-4111

  Gilligan, Timothy ^a  

^a TAUSSIG CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CISPLATIN; ETOPOSIDE;

CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER RISK; CANCER SCREENING; CANCER STAGING; CANCER SURVIVAL; CANCER SURVIVOR; CLINICAL PRACTICE; COMPUTER ASSISTED TOMOGRAPHY; EVIDENCE BASED MEDICINE; FOLLOW UP; HUMAN; LYMPH NODE DISSECTION; MALE; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; ORCHIECTOMY; OVERALL SURVIVAL; PARAAORTIC LYMPH NODE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RADIATION EXPOSURE; REVIEW; RISK BENEFIT ANALYSIS; SECOND CANCER; SEMINOMA; SYSTEMATIC ERROR; TESTIS CANCER; TESTIS NONSEMINOMA CANCER;

HUMANS; MALE; NEOPLASMS, GERM CELL AND EMBRYONAL; NEOPLASMS, SECOND PRIMARY; SURVIVORS; TESTICULAR NEOPLASMS;

EID: 80052486498     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.26026     Document Type: Review

References (21)

1. Altekruse SF, Kosary CL, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2007. Bethesda, MD: National Cancer Institute; 2010. Accessed January 15, 2011.
2. Travis LB, Beard C, Allan JM, et al. Testicular cancer survivorship: research strategies and recommendations. J Natl Cancer Inst. 2010; 102: 1114-1130.
3. Fossa SD, Aass N, Harvei S, Tretli S,. Increased mortality rates in young and middle-aged patients with malignant germ cell tumours. Br J Cancer. 2004; 90: 607-612. (Pubitemid 38297198)
4. Fossa SD, Gilbert E, Dores GM, et al. Noncancer causes of death in survivors of testicular cancer. J Natl Cancer Inst. 2007; 99: 533-544. (Pubitemid 47073556)
5. Zagars GK, Ballo MT, Lee AK, Strom SS,. Mortality after cure of testicular seminoma. J Clin Oncol. 2004; 22: 640-647. (Pubitemid 41095067)
6. Einhorn LH, Williams SD, Loehrer PJ, et al. Evaluation of optimal duration of chemotherapy in favorable-prognosis disseminated germ cell tumors: a Southeastern Cancer Study Group protocol. J Clin Oncol. 1989; 7: 387-391. (Pubitemid 19075021)
7. Warde P, Gospodarowicz MK, Panzarella T, et al. Stage I testicular seminoma: results of adjuvant irradiation and surveillance. J Clin Oncol. 1995; 13: 2255-2262.
8. Read G, Stenning SP, Cullen MH, et al. Medical Research Council prospective study of surveillance for stage I testicular teratoma. Medical Research Council Testicular Tumors Working Party. J Clin Oncol. 1992; 10: 1762-1768. (Pubitemid 23059954)
9. von der Maase H, Specht L, Jacobsen GK, et al. Surveillance following orchidectomy for stage I seminoma of the testis. Eur J Cancer. 1993; 29A: 1931-1934. (Pubitemid 23324346)
10. Choueiri TK, Stephenson AJ, Gilligan T, Klein EA,. Management of clinical stage I nonseminomatous germ cell testicular cancer [abstract]. Urol Clin North Am. 2007; 34: 137-148. Abstract viii. (Pubitemid 46678178)
11. Kollmannsberger C, Moore C, Chi KN, et al. Non-risk-adapted surveillance for patients with stage I nonseminomatous testicular germ-cell tumors: diminishing treatment-related morbidity while maintaining efficacy. Ann Oncol. 2010; 21: 1296-1301.
12. Chung P, Mayhew LA, Warde P, Winquist E, Lukka H,. Management of stage I seminomatous testicular cancer: a systematic review. Clin Oncol (R Coll Radiol). 2010; 22: 6-16.
13. Tarin TV, Sonn G, Shinghal R,. Estimating the risk of cancer associated with imaging related radiation during surveillance for stage I testicular cancer using computerized tomography. J Urol 181: 627-632, 2009; discussion 632-623.
14. Poonacha TK, Go RS,. Level of scientific evidence underlying recommendations arising from the National Comprehensive Cancer Network clinical practice guidelines. J Clin Oncol. 2011; 29: 186-191.
15. Rustin GJ, Mead GM, Stenning SP, et al. Randomized trial of 2 or 5 computed tomography scans in the surveillance of patients with stage I nonseminomatous germ cell tumors of the testis: Medical Research Council Trial TE08, ISRCTN56475197-the National Cancer Research Institute Testis Cancer Clinical Studies Group. J Clin Oncol. 2007; 25: 1310-1315. (Pubitemid 46706876)
16. Sohaib SA, Koh D-M, Husband JE,. The role of imaging in the diagnosis, staging, and management of testicular cancer. Am J Roentgenol. 2008; 191: 387-395.
17. Oldenburg J, Martin JM, Fossa SD,. Late relapses of germ cell malignancies: incidence, management, and prognosis. J Clin Oncol. 2006; 24: 5503-5511. (Pubitemid 46631330)
18. Chamie K, Kurzrick EA, Evans CP, et al. Secondary malignancies among nonseminomatous germ cell tumor cancer survivors. Cancer. 2011; 117: 4219-4230.
19. Gilligan TD, Seidenfeld J, Basch EM, et al. American Society of Clinical Oncology clinical practice guideline on uses of serum tumor markers in adult males with germ cell tumors. J Clin Oncol. 2010; 28: 3388-3404.
20. American Joint Committee on Cancer. Testis. In:, Edge SB, Fritz AG, Byrd DR, et al, eds. AJCC Cancer Staging Manual. 7th ed. New York: Springer; 2010: 469-473.
21. Buchler T, Kubankova P, Boublikova L, et al. Detection of second malignancies during long-term follow-up of testicular cancer survivors. Cancer. 2011; 117: 4212-4218.